The iconic status of Viagra, and its parent company copyright, presents a complex question for those seeking capital. While revenues initially soared , the impending patent lapse and growing generic presence https://alexiawdmk315866.webbuzzfeed.com/41851452/the-blue-pill-and-big-pharma-a-uncertain-investment